6505--PYLARIFY (F18 Piflufolastat)
ID: 36C25724Q1037Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF257-NETWORK CONTRACT OFFICE 17 (36C257)ARLINGTON, TX, 76006, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/7fd57dd6ee4e45eb8834870803d619f0/view
Timeline
    Description

    The Department of Veterans Affairs, through the Network Contracting Office 17, intends to award a sole-source procurement for PYLARIFY® (Piflufolastat F18 Injection) from Progenics Pharmaceuticals. The procurement involves the acquisition of 500 units of this pharmaceutical product, which is critical for the agency's healthcare services. Progenics Pharmaceuticals has confirmed that it is the sole manufacturer and authorized supplier of PYLARIFY®, necessitating this non-competitive procurement under the statutory authority of 41 U.S.C. 3304(a)(1). Interested parties are invited to submit capability statements or proposals within seven days of the notice's publication; otherwise, the contract will be awarded to Progenics without further notice. For inquiries, contact Contract Specialist Vance Farrell at vance.farrell@va.gov or call 210-694-6379.

    Point(s) of Contact
    Vance FarrellContract Specialist
    (210) 694-6379
    vance.farrell@va.gov
    Files
    Title
    Posted
    36C25724Q1037.docx
    The Department of Veterans Affairs (VA), through the Network Contracting Office 17, intends to award a sole-source procurement for PYLARIFY® (Piflufolastat F18 Injection) from Progenics Pharmaceuticals. They plan to order 500 units against an existing VA contract. Progenics has confirmed it is the sole manufacturer and supplier of this product. This notice indicates the intent to proceed without competitive bidding, following the statutory authority outlined in 41 U.S.C. 3304(a)(1). Although the notice is not a formal request for quotations, it invites other capable sources to submit proposals or capability statements within seven days of the notice’s publication. If no competing offers are received, the contract will be awarded to Progenics without further notice. This action reflects the VA’s necessity to procure specific pharmaceuticals to meet agency requirements efficiently and effectively.
    Lifecycle
    Title
    Type
    6505--PYLARIFY (F18 Piflufolastat)
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--Ga68 PSMA Injection (Illucix)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.
    6550--VA Northern California Health Care System, Mather Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the provision of radiopharmaceuticals and related supplies for the VA Northern California Health Care System, with a contract period spanning from April 1, 2025, to March 31, 2030. The procurement includes the delivery of various diagnostic and therapeutic radiopharmaceuticals, which are critical for effective healthcare services, particularly for veterans requiring advanced medical treatments. Contractors must comply with regulatory standards from the Nuclear Regulatory Commission and the Food and Drug Administration, ensuring quality control and timely delivery, especially for emergency services, with a minimum guaranteed contract value of $100 and a maximum of $2.5 million for total orders. Interested parties should submit their questions in writing by October 14, 2024, and direct their inquiries to Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Calcitonin Gene-Related Peptides (CGRP) to support various healthcare programs, including those for Consolidated Mail Order Pharmacies and State Veterans Homes. The contract will require the successful offeror to provide a consistent supply of specified CGRP products, which are critical for treating patients with certain medical conditions, ensuring uninterrupted access to these essential medications. The solicitation is expected to be released on or about October 10, 2024, with a closing date of October 24, 2024, and interested parties should direct inquiries to Contracting Officer Chris Carthron at Christopher.Carthron@va.gov or by phone at (708) 786-4980. The contract will span one year with four additional one-year options, and all relevant documents will be available electronically at sam.gov.
    J065--BD Pyxis Service - VISN
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for maintenance services related to BD Pyxis medication systems, primarily to Carefusion Solutions, LLC. This contract, designated as 36C26324Q1213, aims to ensure continuous maintenance, including technical support, parts repair, preventive maintenance, and software updates for the BD Pyxis systems utilized across various VA facilities in the Midwest. The initiative is critical for sustaining automated dispensing systems that enhance medication management and safety for veterans. Interested vendors not currently representing Carefusion may submit capability statements to Contract Specialist Emanuel Nevarez at emanuel.nevarez@va.gov, with the contract set to begin on January 1, 2025, and spanning five years.
    Pramipexole Tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is preparing to issue a solicitation for a national requirements contract for Pramipexole Tablets, which are essential medications used primarily for the treatment of Parkinson's disease and restless legs syndrome. The procurement will include various dosages of Pramipexole (0.125 MG, 0.25 MG, 0.5 MG, 0.75 MG, 1 MG, and 1.5 MG) packaged in 90 count bottles, and the contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. This acquisition is unrestricted and fully competitive, aimed at establishing a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should prepare for the solicitation, projected for October 2024, and may contact Ryan Guarnere at 215-737-2571 or Ryan.Guarnere@dla.mil for further inquiries.
    J065--INTENT TO SOLE SOURCE | CAREFUSION Pyxis Maintenance and Support Services | ONE BASE PLUS FOUR OPTION YEARS | CLARSBURG VA MEDICAL CENTER
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to award a sole-source contract for maintenance and support services for CareFusion Pyxis automated medication dispensing systems at the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia. The contract will cover a base year from November 1, 2024, to October 31, 2025, with options for four additional years, requiring comprehensive preventive and corrective maintenance services, including parts, labor, and 24/7 remote support from fully qualified field service engineers authorized by the original equipment manufacturer. These services are critical to ensuring the safety and operational efficiency of medical equipment used in patient care. Interested vendors must provide detailed company and capability information if they wish to challenge the sole-source designation, and inquiries can be directed to Contracting Officer Amy Walter at AMY.WALTER1@VA.GOV.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30-count bottles. The Request for Proposal (RFP) outlines specific requirements for offerors, including pricing for a base year and four optional one-year periods, compliance with federal regulations, and the provision of unique National Drug Code (NDC) numbers. This procurement is crucial for ensuring a reliable supply of essential medications to support veterans and related healthcare providers under the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. Interested parties must submit their proposals by October 8, 2024, at 2:30 PM Central Standard Time, and can direct inquiries to Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    6515--36C242-24-AP-4875 | 528-25-1-4085-0001 BkSpecto Ultrasound
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for the procurement of a BK Specto Ultrasound Unit and associated probes for urologic procedures, effective October 1, 2024. This procurement is necessitated by the discontinuation of critical disposable biopsy guides for existing ultrasound probes, which has severely limited the operational capacity of the urology department, leaving them reliant on a single remaining probe. The BK Specto Ultrasound Unit is essential for conducting prostate biopsies and ensuring effective patient care in urology, following the obsolescence of previous equipment. Interested suppliers may submit capability statements to Contract Specialist Barry Sawyer at Barry.Sawyer@va.gov by September 30, 2024, at 4:00 PM (ET), as this notice is not a request for quotes.
    DO FY25 Rubidium RB-82 Generator - IC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a sole source contract for the procurement of a Rubidium RB-82 Generator, specifically for the Iowa City VA Health Care System. The generator, produced by Bracco Diagnostics, Inc., is essential for producing rubidium Rb 82 chloride injection, which is used in Positron Emission Tomography (PET) imaging to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease. This specialized equipment must comply with FDA and NRC requirements and will be delivered every 28 days starting October 1, 2024. Interested vendors may express their capabilities to be considered, but Bracco Diagnostics, Inc. has been identified as the exclusive source for this product. For further inquiries, interested parties can contact Evan Beachy at evan.beachy@va.gov.